Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Cytokinetics Announces Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Thursday, July 16, 2020 7:15 PM EDT
Cytokinetics, Incorporated today announced the pricing of an underwritten public offering of 7,291,667 shares of its common stock at a price to the public of $24.00 per share, before underwriting discounts and commissions.
In this article: CYTK
5 Tiny Biotech Stocks With Superb Growth Potential
Article By:
Swarup Gupta
Wednesday, February 13, 2019 11:40 AM EDT
After a disastrous end to 2018, pharma stocks have started the New Year on a considerably strong note. Here are several biotech stocks which would be a smart choice to invest in.
3 Biotechs With Upcoming Data To Be Presented At Conferences
Article By:
Scott Matusow
Tuesday, June 12, 2018 5:24 AM EDT
Biotech stocks tend to have strong movement when their respective companies have binary events upcoming in short order. Here are 3 companies with upcoming data to be presented at data conferences this week.
Is Gilead Sciences About To Buy Vertex For $45 Billion?
What's your take on $CYTK?
Small Cap Best & Worst Report - October 9, 2014
Yes, $CYTK is a pos. If it gets over 4 again, I'm out.